NLRP3 and metabolic dysfunction-associated steatohepatitis: These results tell us that NLRP3 inflammasome activation in the liver or in HSCs may be an important early pathogenic mechanism to turn on the inflammatory response and thereby instigate liver fibrosis during NASH.